Full View

Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis

Y Guo, L Li, S Hu - Renal Failure, 2023 - Taylor & Francis
Background Fibroblast growth factor 21 (FGF21) is deemed to play an important role in
kidney outcomes, while the association between FGF21 and various kidney diseases …
被引用次数：4 相关文章
[HTML] nih.gov

[HTML][HTML] Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis

G Yong, L Li, S Hu - Renal Failure, 2023 - ncbi.nlm.nih.gov
Background Fibroblast growth factor 21 (FGF21) is deemed to play an important role in
kidney outcomes, while the association between FGF21 and various kidney diseases …

Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis.

G Yong, L Li, S Hu - Renal Failure, 2023 - europepmc.org
Background Fibroblast growth factor 21 (FGF21) is deemed to play an important role in
kidney outcomes, while the association between FGF21 and various kidney diseases …

Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis

Y Guo, L Li, S Hu - Renal Failure, 2023 - search.proquest.com
Background Fibroblast growth factor 21 (FGF21) is deemed to play an important role in
kidney outcomes, while the association between FGF21 and various kidney diseases …

Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis

G Yong, L Li, S Hu - Renal failure, 2023 - pubmed.ncbi.nlm.nih.gov
Background Fibroblast growth factor 21 (FGF21) is deemed to play an important role in
kidney outcomes, while the association between FGF21 and various kidney diseases …